Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Brain-Zapping headset aims to sharpen your mind in virtual reality

NCT ID NCT06782360

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study tested whether a head-mounted sensor and mild electrical stimulation on the ear could help healthy adults stay focused and resist cybersickness during virtual reality tasks. 45 volunteers completed attention, multitasking, and motion-sickness tests while receiving either real or sham stimulation. The goal was to see if the device could measure and improve cognitive performance in real time.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
transcutaneous auricular neurostimulation (tAN) device
What this could lead to
If it works, this could point toward a non-drug way to improve concentration and reduce motion sickness in virtual reality.
What could go wrong
This is a small, early-stage study in healthy volunteers, not patients. The results may not apply to real-world conditions or lead to a commercial product.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

45 people

The number who actually took part.

Started

Apr 2025

Finished

Mar 2026

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Healthy human subjects between the ages of 18 and 55 * Normal color vision and near visual acuity of 20/30 without correction. * Participant is right-hand dominant * Proficient in the English language * Ability to understand the explanations and instructions given by the study personnel Exclusion Criteria: * Participant presents current evidence of an uncontrolled and/or clinically significant medical condition or psychiatric condition * Participant is participating in another interventional trial within 90 days prior to or throughout duration of trial * Participant has a prior diagnosis of post-traumatic stress disorder, acute stress disorder, or generalized anxiety disorder * Participant has a diagnosis of attention deficit hyperactivity disorder (ADHD) and/or is currently taking medications for the treatment of ADHD. * Current or recent history of substance abuse or drug dependence including nicotine and alcohol, or use of mind-altering drugs in the past 30 days. * Participant has abnormal ear anatomy, ear infection present, or ear piercing that could interfere with stimulation * Participant has a recent history of epileptic seizures; including photosensitive epilepsy * Participant has a recent history of neurologic diseases or traumatic brain injury * Participant has presence of implanted medical devices (e.g., pacemakers, cochlear prostheses, neurostimulators) * Females who are pregnant or lactating * Participant has any other significant disease or disorder which, in the opinion of the Investigator, may either put the participants are risk because of participation in the trial, or may influence the result of the trial, or the participant's ability to participate in the trial * Sensitivity to bright screens or virtual reality displays * Recent history of neurological and psychiatric disease/disorder

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cognitive change are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • OpenBCI

    Brooklyn, New York, 11222, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.